Editorial Type: Case Reports
 | 
Online Publication Date: 01 Jul 2007

Dystrophin-Deficient Muscular Dystrophy in a Weimaraner

DVM, PhD,
DVM,
DVM, Diplomate ACVIM (Neurology),
DVM, PhD, Diplomate ACVIM,
PhD, DVM, Diplomate ACVP, and
DVM, PhD, Diplomate ACVIM, Diplomate ECVIM
Article Category: Other
Page Range: 227 – 232
DOI: 10.5326/0430227
Save
Download PDF

A 2-year-old, male Weimaraner with muscular dystrophy was presented with generalized muscle atrophy of the limbs; hypertrophy of the neck, infraspinatus, and lingual muscles; dysphagia; and regurgitation. Unilateral cryptorchidism, unilateral renal agenesis, and hiatal hernia were also detected. Spontaneous muscle activity was identified on myography. Serum creatine kinase was markedly elevated. Immunohistochemical staining for dystrophin was restricted to suspected revertant (characteristics of immaturity) fibers. Histologically, skeletal myofiber degeneration, endomysial fibrosis, and mineralization were present. Following euthanasia, necropsy revealed hypertrophy of the diaphragm and cardiac muscle fibrosis. This case of muscular dystrophy represents a slowly progressive form with organ agenesis.

Introduction

Muscular dystrophy has been described in humans, dogs, and cats; it is composed of a heterogeneous group of hereditary, degenerative myopathies.1 The most common form of muscular dystrophy in humans and dogs arises from a mutation in the gene for the dystrophin protein that disrupts the skeletal and cardiac muscles’ dystrophin-glycoprotein complex.1 The human form of dystrophin deficiency is called Duchenne’s muscular dystrophy.2 In dogs, dystrophies have been described in several breeds, including the golden retriever, Labrador retriever, Irish terrier, German shorthaired pointer, rat terrier, Belgian Groenendaeler shepherd, Samoyed, Japanese spitz, Brittany spaniel, and an Old English sheepdog.312 A range of clinical phenotypes has been described in humans, including severe forms that progress rapidly and milder forms that have a prolonged course.1 In previously reported dogs with muscular dystrophy, clinical signs usually developed at <6 months of age.5,9,13,14

The purpose of this report is to describe a dystrophin-deficient muscular dystrophy in an adult male Weimaraner. To the authors’ knowledge, this is the first report of a dystrophin-deficiency muscular dystrophy in a Weimaraner.

Case Report

A 2-year-old, male Weimaraner was examined for a 1-year history of regurgitation, exercise intolerance, and dysphagia. The frequency of regurgitation and excessive drooling had increased in the last month, and a hiatal hernia was suspected. Abnormal findings on physical examination included cryptorchidism, poor body condition (body condition score of 1.5/5), and atrophy of most major muscle groups. Muscles of the neck, infraspinatus, and tongue were hypertrophied. Periodically, the dog developed muscle spasms of the neck that lasted 10 to 30 seconds. Gait was short-strided in the thoracic and pelvic limbs, without overt ataxia or neurological deficits. Based on these findings, a primary myopathy was suspected. Differential diagnoses included degenerative disorders (e.g., muscular dystrophy, storage disease), an inflammatory myopathy (e.g., Toxoplasma gondii, Neospora caninum), an immune-mediated disorder (e.g., polymyositis), neoplasia (e.g., lymphoma), and metabolic diseases (e.g., mitochondrial myopathy).

Results of a hemogram indicated a leukocytosis (21,500 cells/μL, reference range 6000 to 17,000 cells/μL) with an absolute neutrophilia (18,060 cells/μL, reference range 3000 to 11,500 cells/μL). Serum creatinine kinase ([CK] 32,672 U/L, reference range 68 to 400 U/L) and alanine aminotransferase ([ALT] 305 U/L, reference range 10 to 130 U/L) were elevated. Serum aspartate aminotransferase (AST) was not analyzed. Serum antibody titers for Toxoplasma gondii were negative for immunoglobulin G (IgG) and did not indicate an active infection on immunoglobulin M (IgM) assay (1:128, active infection >1:1024a). Serum titers for Neospora caninum were negative. Urinalysis revealed myoglobinuria without hemoglobinuria, which was confirmed by microfiltration.b

Radiographs (taken with the dog under general anesthesia with isofluranec in oxygen) of the pharynx identified a soft-tissue swelling near the angle of the mandible, with no bony involvement. Radiographs of the thorax and abdomen revealed the stomach was protruding through the esophageal hiatus into the thorax. A small mass at the ventral margin of the diaphragm was later identified as a thickening of the diaphragm musculature around its central tendon. Echocardiography was performed to assess cardiac muscle function, and no evidence of a cardiomyopathy was seen except for hyperechoic regions within the left ventricular free wall.1 Moderate mitral regurgitation was identified. Systolic function and transaortic and transpulmonic velocities were normal.

Electrophysiology was performed with the dog under general anesthesia (with isofluranec in oxygen). Both the paraspinal and appendicular musculature had grade 4/4 abnormal spontaneous activity consisting of complex repetitive discharges with isolated fibrillation potentials. Peroneal motor-nerve conduction velocity was within normal limits (81 meters per second, reference value >53 meters per second); however, the compound motor-unit action potential amplitude was significantly reduced at the hip, tarsus, and stifle recording sites (14.6 mV, 3.4 mV, and 4.5 mV, respectively).1517 Electrophysiological results were most consistent with a myopathy.

Muscle biopsies were collected from the infraspinatus, sternohyoideus, and ventral tongue muscles. The biopsies were either fixed in 10% formalin and submitted for general histopathology, or they were refrigerated and shipped overnight for histochemical staining. The fresh biopsy tissue was flash-frozen in isopentane that was precooled in liquid nitrogen, and it was stored at −80°C until further analysis.d,16,18 Specimens from all biopsied muscles were also submitted for aerobic bacterial and fungal cultures. Cultures were negative except for those of the tongue, which grew a coagulase-negative staphylococcus that was likely a contaminant or opportunistic infection.

Histopathological changes typical of a muscular dystrophy were present in all three muscles. Changes included a marked variability in myofiber size with numerous, small, round to angular atrophied fibers; numerous fibers with multiple internal nuclei; extensive endomysial fibrosis; and clusters of degenerating and regenerating fibers with scattered myofiber mineralization [Figure 1A]. The central nuclei in most fibers were indicative of a chronic myopathic change and not regeneration. There were a few basophilic regenerating fibers of very small diameter, but most were large with degenerative changes.

For immunohistochemical analysis of dystrophin, fresh-frozen sections of muscle were incubated with monoclonal antibodies against the rod domain (1:20; NCL-DYS1) and carboxy terminus (1:20; NCL-DYS2) of dystrophine [Figure 1B, 1C]. An antibody against spectrin (1:100; NCL-SPEC2) was used as a control for membrane integrity [Figure 1D]. Compared to the control muscle, dystrophin staining was restricted to the sarcolemma of a few fibers. These fibers may have indicated revertant fibers (those having immature developmental characteristics), which can be seen with abnormalities of dystrophin in various species. Monoclonal antibody staining for dystrophin deoxyribonucleic acid was not performed, however.19,20

Based on the presence of severe muscle weakness and the poor body condition, the dog was euthanized and a necropsy was performed. Necropsy findings included agenesis of the right kidney and ureter and an abdominal right testicle. The musculature of the limbs was grossly atrophied, but the ventral tongue, larynx, and dorsal neck muscles were grossly hypertrophied [Figure 2]. Similar to the biopsy findings, all muscles evaluated (quadriceps, triceps, sternothyroideus, semimembranosus, sternocephalicus, platysma, genioglossus muscles) displayed the same dystrophic pattern of degeneration, regeneration, and fibrosis. The esophagus was grossly normal. The entire stomach was herniated through a diverticulum of the esophageal hiatus of the diaphragm, which expanded to >10 cm. The diaphragmatic musculature was markedly thickened (with prominent striations), which formed a 1.5-cm band around the accentuated central tendon [Figure 3]. Microscopically, the diaphragm contained similar degeneration, regeneration, fibrosis, and mineralization. A trichrome stain of the diaphragm highlighted the marked endomysial fibrosis [Figure 4]. In the heart, the ventricles (especially the left) were moderately dilated, with concentric mural and septal hypertrophy. Microscopically, anastomosing and some-what perivascular myocardial fibrosis with mineralization and myofiber atrophy was seen within the posterobasal left ventricular free-wall myocardium, with sparing of subendocardial and subepicardial regions. No evidence of active myodegeneration or necrosis was seen [Figure 5]. No significant lesions were identified in the central nervous system or in the recurrent laryngeal, sciatic, tibial, peroneal, and radial nerves.

Discussion

Most reported cases of muscular dystrophy in dogs have been associated with dystrophin deficiency rather than expression of an abnormal protein.21 Histologically, typical findings in muscle biopsy specimens have included myofiber degeneration, regeneration, variations in myofiber size, fibrosis, and sometimes calcific deposits.1 All of these changes were identified in the muscles of the Weimaraner in this report.

An unusual aspect of this case was the late presentation (2 years of age) for clinical evaluation. Most dogs with muscular dystrophy are evaluated at <1 year of age because of clinical signs of weakness, exercise intolerance, muscle wasting, and dysphagia that worsen in severity over several months.3,8,9,22 As different mutations in the dystrophin gene can occur, the clinical signs of muscular dystrophy can vary, depending on the size of the deletion or severity of the mutation.10 For example, a truncated form of dystrophin has been described in Japanese spitz dogs that have severe dystrophic changes.10 In these dogs, a 70 to 80 kDa (kilodalton) fragment was recognized by the monoclonal antibody DYS-2.10 Since the smallest functional dystrophin gene has recently been shown to be between 150 and 165 kDa, the 70 to 80 kDa fragment found in the spitz dogs would not have been large enough to protect them from a dystrophic process.23,24 The slower course of the disease in the Weimaraner reported here may have reflected a smaller deletion or a less severe mutation of the dystrophin gene. Further diagnostics beyond the histopathological determination of the dystrophic phenotype and immunohistochemical analysis of muscle biopsy sections for localization of dystrophin and dystrophin-related proteins would have been necessary to determine the precise classification of the dystrophin disorder in this dog.25 Unfortunately, neither Western blotting nor mutational analyses were performed on this case. For routine clinical evaluations, staining of muscle sections for the presence or absence of dystrophin and related proteins has been considered adequate.26

The case reported here displayed many similarities to golden retriever muscular dystrophy, including enlargement of the base of the tongue, diaphragm, and pharyngeal muscles. The dog in this case report had many other similarities to muscular dystrophy of golden retrievers, including clinical, biochemical, histochemical, and immunohistochemical changes.14,27 The elevation in serum ALT may have been related to muscle necrosis.27 Electromyographic findings were also similar, with complex repetitive discharges being the predominant abnormality.28,29 The cardiac changes found on the echocardiogram and necropsy were similar to those identified in affected golden retrievers and in humans with Duchenne’s muscular dystrophy.28,30,31 Histopathological myocardial changes are corroborative of ongoing, gradual myocardial loss and replacement fibrosis. Although sparing of subepicardial regions is more unique to this case, a somewhat perivascular distribution without evidence of mural or luminal changes was similar to previous observations and may indicate vascular factors were involved in the pathogenesis. 28 The hernia identified at necropsy in the esophageal hiatus has also been described in golden retrievers and Labrador retrievers with muscular dystrophy.1,3,32 The progressive nature of the clinical signs reported in the current case was also typical of most reports of dystrophin deficiency in people, dogs, and cats.2,18

In contrast to golden retriever muscular dystrophy and Labrador retriever muscular dystrophy, this case also had right-sided cryptorchidism and agenesis of the right kidney and ureter.1 It was unknown if these problems represented an unrelated mutation or some separate but linked abnormality. The Weimaraner in this report was not stunted in growth, which has been reported in affected golden retrievers. 3,29 The course of the disease and age at death can be variable in the golden retriever, with dogs living several months to several years of age. It was not determined if muscular dystrophy in this case was associated with a spontaneous, new mutation or if it was a typical X-linked, recessive defect. Information was not available on littermates, and mutational analysis was not performed.

Conclusion

Dystrophin-deficient muscular dystrophy was diagnosed in a 2-year-old, male Weimaraner via immunohistochemistry. This dog had a chronic, progressive disease course, and the dystrophy was associated with agenesis of the right kidney. Future studies identifying the dystrophin gene size and exon deletions in clinical cases may be warranted to determine functionality of the dystrophin protein, inheritance pattern in the Weimaraner breed, and the presence of revertant protein.

Infectious Diseases Laboratory, University of Georgia, Athens, GA 30602

Microcon; Millipore Corp., Billerica, MA 01821

Isoflurane; Abbott Laboratories, North Chicago, IL 60064

Comparative Neuromuscular Laboratory; University of California–San Diego, La Jolla, CA 92903

NCL-DYS1, NCL-DYS2, NCL-SPEC2; Novocastra Laboratories—monoclonal antibodies to dystrophin proteins 1 and 2 and spectrin protein 2, respectively; Novocastra Laboratories, Newcastle-upon-Tyne, United Kingdom

Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).
Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).
Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).
Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).Figures 1A–1D—. Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).
Figures 1A–1D Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).

Citation: Journal of the American Animal Hospital Association 43, 4; 10.5326/0430227

Figure 2—. Postmortem photograph of the dog in Figure 1, showing swelling of the neck (A), prominent maxillofacial musculature (B), and thickening of the tongue (C) from muscular hypertrophy. The apparent brachygnathism and glossal retraction are secondary to constriction and fibrosis of the affected musculature. Atrophy of the temporalis (arrow) and masseter muscles can also be seen.Figure 2—. Postmortem photograph of the dog in Figure 1, showing swelling of the neck (A), prominent maxillofacial musculature (B), and thickening of the tongue (C) from muscular hypertrophy. The apparent brachygnathism and glossal retraction are secondary to constriction and fibrosis of the affected musculature. Atrophy of the temporalis (arrow) and masseter muscles can also be seen.Figure 2—. Postmortem photograph of the dog in Figure 1, showing swelling of the neck (A), prominent maxillofacial musculature (B), and thickening of the tongue (C) from muscular hypertrophy. The apparent brachygnathism and glossal retraction are secondary to constriction and fibrosis of the affected musculature. Atrophy of the temporalis (arrow) and masseter muscles can also be seen.
Figure 2 Postmortem photograph of the dog in Figure 1, showing swelling of the neck (A), prominent maxillofacial musculature (B), and thickening of the tongue (C) from muscular hypertrophy. The apparent brachygnathism and glossal retraction are secondary to constriction and fibrosis of the affected musculature. Atrophy of the temporalis (arrow) and masseter muscles can also be seen.

Citation: Journal of the American Animal Hospital Association 43, 4; 10.5326/0430227

Figure 3—. Cross-sectional photograph of unfixed strips of the diaphragm, including the pars costalis and central tendon from a normal, 7-year-old, 20-kg, female, mixed-breed dog (A) and the affected Weimaraner (B) of Figure 2. Both specimens contain comparable areas of the pars costalis and central tendon. The diaphragmatic specimen of the affected Weimaraner is short, thick, and pale primarily from fibrosis (arrow) (marker=1 cm).Figure 3—. Cross-sectional photograph of unfixed strips of the diaphragm, including the pars costalis and central tendon from a normal, 7-year-old, 20-kg, female, mixed-breed dog (A) and the affected Weimaraner (B) of Figure 2. Both specimens contain comparable areas of the pars costalis and central tendon. The diaphragmatic specimen of the affected Weimaraner is short, thick, and pale primarily from fibrosis (arrow) (marker=1 cm).Figure 3—. Cross-sectional photograph of unfixed strips of the diaphragm, including the pars costalis and central tendon from a normal, 7-year-old, 20-kg, female, mixed-breed dog (A) and the affected Weimaraner (B) of Figure 2. Both specimens contain comparable areas of the pars costalis and central tendon. The diaphragmatic specimen of the affected Weimaraner is short, thick, and pale primarily from fibrosis (arrow) (marker=1 cm).
Figure 3 Cross-sectional photograph of unfixed strips of the diaphragm, including the pars costalis and central tendon from a normal, 7-year-old, 20-kg, female, mixed-breed dog (A) and the affected Weimaraner (B) of Figure 2. Both specimens contain comparable areas of the pars costalis and central tendon. The diaphragmatic specimen of the affected Weimaraner is short, thick, and pale primarily from fibrosis (arrow) (marker=1 cm).

Citation: Journal of the American Animal Hospital Association 43, 4; 10.5326/0430227

Figure 4—. This photomicrograph of the diaphragm of the affected Weimaraner with muscular dystrophy demonstrates areas of endomysial fibrosis (blue, A) that separate and surround hypertrophic (B), atrophic (C), and necrotic, fragmented (D) muscle fibers (Masson’s trichrome, bar=85 μm).Figure 4—. This photomicrograph of the diaphragm of the affected Weimaraner with muscular dystrophy demonstrates areas of endomysial fibrosis (blue, A) that separate and surround hypertrophic (B), atrophic (C), and necrotic, fragmented (D) muscle fibers (Masson’s trichrome, bar=85 μm).Figure 4—. This photomicrograph of the diaphragm of the affected Weimaraner with muscular dystrophy demonstrates areas of endomysial fibrosis (blue, A) that separate and surround hypertrophic (B), atrophic (C), and necrotic, fragmented (D) muscle fibers (Masson’s trichrome, bar=85 μm).
Figure 4 This photomicrograph of the diaphragm of the affected Weimaraner with muscular dystrophy demonstrates areas of endomysial fibrosis (blue, A) that separate and surround hypertrophic (B), atrophic (C), and necrotic, fragmented (D) muscle fibers (Masson’s trichrome, bar=85 μm).

Citation: Journal of the American Animal Hospital Association 43, 4; 10.5326/0430227

Figure 5—. This photomicrograph of the myocardium of the affected Weimaraner demonstrates marked myocardial fibrosis (A), which separates and surrounds atrophic cardiac myocytes (B), and areas of mineralization (C) (Hematoxylin and eosin stain, bar=25 μm).Figure 5—. This photomicrograph of the myocardium of the affected Weimaraner demonstrates marked myocardial fibrosis (A), which separates and surrounds atrophic cardiac myocytes (B), and areas of mineralization (C) (Hematoxylin and eosin stain, bar=25 μm).Figure 5—. This photomicrograph of the myocardium of the affected Weimaraner demonstrates marked myocardial fibrosis (A), which separates and surrounds atrophic cardiac myocytes (B), and areas of mineralization (C) (Hematoxylin and eosin stain, bar=25 μm).
Figure 5 This photomicrograph of the myocardium of the affected Weimaraner demonstrates marked myocardial fibrosis (A), which separates and surrounds atrophic cardiac myocytes (B), and areas of mineralization (C) (Hematoxylin and eosin stain, bar=25 μm).

Citation: Journal of the American Animal Hospital Association 43, 4; 10.5326/0430227

References

  • 1
    Schatzberg SJ, Shelton GD. Newly identified neuromuscular disorders. Vet Clin North Am Small Anim Pract 2004;34:1497–1524.
  • 2
    Shelton GD, Engvall E. Muscular dystrophies and other inherited myopathies. Vet Clin North Am Small Anim Pract 2002;32:103–124.
  • 3
    Kornegay JN, Tuler SM, Miller DM, et al. Muscular dystrophy in a litter of golden retriever dogs. Muscle Nerve 1988;11:1056–1064.
  • 4
    Bergman RL, Inzana KD, Monroe WE, et al. Dystrophin-deficient muscular dystrophy in a Labrador retriever. J Am Anim Hosp Assoc 2002;38:255–261.
  • 5
    Wentink G, Linde-Sipman JS, van der meijer AEFH, et al. Myopathy with a possible recessive X-linked inheritance in a litter of Irish terriers. Vet Pathol 1972;9:328–349.
  • 6
    Schatzberg SJ, Olby NJ, Breen M, et al. Molecular analysis of a spontaneous dystrophin ‘knockout’ dog. Neuromuscul Disord 1999;9:289–295.
  • 7
    Wetterman CA, Harkin KR, Cash WC, et al. Hypertrophic muscular dystrophy in a young dog. J Am Vet Med Assoc 2000;216:878–881.
  • 8
    van Ham LML, Desmidt M, Tshamala M. Canine X-linked muscular dystrophy in Belgian Groenendaeler shepherds. J Am Anim Hosp Assoc 1993;29:570–574.
  • 9
    Presthus J, Nordstoga K. Congenital myopathy in a litter of Samoyed dogs. Prog Vet Neurol 1993;4:37–40.
  • 10
    Jones BR, Brennan S, Mooney CT, et al. Muscular dystrophy with truncated dystrophin in a family of Japanese spitz dogs. J Neurol Sci 2004;217:143–149.
  • 11
    van Ham LML, Roels SLMF, Hoorens FK. Congenital dystrophy-like myopathy in a Brittany spaniel puppy. Prog Vet Neurol 1995;6:135–138.
  • 12
    Wieczorek LA, Garosi LS, Shelton GD. Dystrophin-deficient muscular dystrophy in an Old English sheepdog. Vet Rec 2006;158: 270–273.
  • 13
    Kornegay JN. Golden retriever myopathy. In: Bonagura JD, ed. Current Veterinary Therapy IX, Small Animal Practice. Philadelphia: WB Saunders, 1986:792–794.
  • 14
    Valentine BA, Cooper BJ, Cummings JF, et al. Progressive muscular dystrophy in a golden retriever dog: light microscope and ultrastructural features at 4 and 8 months. Acta Neuropathol (Berl) 1986;71:301–310.
  • 15
    Lee AF, Bowen JM. Evaluation of motor nerve conduction velocity and latency in the dog. Am J Vet Res 1970;31:1361–1366.
  • 16
    Dubowitz V. Muscle Biopsy. In: Muscle Biopsy: A Practical Approach. 2nd ed. Philadelphia: Bailliere Tindall, 1985:19–40.
  • 17
    Walker TL, Redding RW, Braund KG. Motor nerve conduction velocity and latency in the dog. Am J Vet Res 1979;40:1433–1439.
  • 18
    Nonaka I. Animal models of muscular dystrophies. Lab Anim Sci 1998;48:8–17.
  • 19
    Thanh LT, Nguyen TM, Helliwell TR, et al. Characterization of revertant muscle fibers in Duchenne muscular dystrophy, using exon-specific monoclonal antibodies against dystrophin. Am J Hum Genet 1995;56:725–731.
  • 20
    Winnard AV, Mendell JR, Prior TW, et al. Frameshift deletions of exons 3–7 and revertant fibers in Duchenne muscular dystrophy: mechanisms of dystrophin production. Am J Hum Genet 1995;56:158–166.
  • 21
    Shelton GD, Engvall E. Canine and feline models of human inherited muscle diseases. Neuromuscul Disord 2005;15:127–138.
  • 22
    Mckerrell RE, Braund KG. Hereditary myopathy in Labrador retrievers: clinical variations. J Small Anim Pract 1987;28:479–489.
  • 23
    Sakamoto M, Yuasa K, Yoshimura M, et al. Micro-dystrophin cDNA ameliorates dystrophic phenotypes when introduced into mdx mice as a transgene. Biochem Biophys Res Commun 2002;293: 1265–1272.
  • 24
    Harper SQ, Hauser MA, DelloRusso C, et al. Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy. Nat Med 2002;8:253–261.
  • 25
    Shelton GD. Muscular dystrophies: expanding our knowledge in companion animals. Vet J 2004;168:6–8.
  • 26
    Vogel H, Zamecnik J. Diagnostic immunohistology of muscle diseases. J Neuropathol Exp Neurol 2005;64:181–193.
  • 27
    Valentine BA, Blue JT, Shelley SM, et al. Increased serum alanine aminotransferase activity associated with muscle necrosis in the dog. J Vet Intern Med 1990;4:140–143.
  • 28
    Valentine BA, Cummings JF, Cooper BJ. Development of Duchenne-type cardiomyopathy. Morphologic studies in a canine model. Am J Pathol 1989;135:671–678.
  • 29
    Valentine BA, Kornegay JN, Cooper BJ. Clinical electromyographic studies of canine X-linked muscular dystrophy. Am J Vet Res 1989;50:2145–2147.
  • 30
    Moise NS, Valentine BA, Brown CA, et al. Duchenne’s cardiomyopathy in a canine model electrocardiographic and echocardiographic studies. J Am Coll Cardiol 1991;17:812–820.
  • 31
    Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 2003;99:1–19.
  • 32
    Blot S, Tshamala M, Thibaud JL. A new canine model of dystrophinopathy in a Labrador retriever. Proc 15th Europ Soc Veterinary Neurol, Philadelphia 2002:252.
Copyright: Copyright 2007 by The American Animal Hospital Association 2007
<bold>
  <italic toggle="yes">Figures 1A–1D</italic>
</bold>
—
Figures 1A–1D

Histopathology and dystrophin immunocytochemistry of the infraspinatus muscle of a 2-year-old, male Weimaraner with muscular dystrophy. (A) Variations in myofiber size, central nuclei, extensive endomysial fibrosis, and myofiber degeneration are consistent with a dystrophic phenotype (Hematoxylin and eosin stain, bar=100 μm). (B) Immunocytochemistry for dystrophin 1 protein (DYS1), showing numerous negatively stained fibers (blue-grey) and small numbers of positively stained fibers (arrow pointing to brown sarcolemmal staining in possible revertant fibers) (bar=100 μm). (C) Sarcolemmal staining was negative (blue-grey) in all muscle fibers following staining for dystrophin protein 2 (DYS2) (bar=100 μm). (D) Positive sarcolemmal staining (brown, arrows) was found following incubation with an antibody (SPEC2) against spectrin (bar=100 μm).


<bold>
  <italic toggle="yes">Figure 2</italic>
</bold>
—
Figure 2

Postmortem photograph of the dog in Figure 1, showing swelling of the neck (A), prominent maxillofacial musculature (B), and thickening of the tongue (C) from muscular hypertrophy. The apparent brachygnathism and glossal retraction are secondary to constriction and fibrosis of the affected musculature. Atrophy of the temporalis (arrow) and masseter muscles can also be seen.


<bold>
  <italic toggle="yes">Figure 3</italic>
</bold>
—
Figure 3

Cross-sectional photograph of unfixed strips of the diaphragm, including the pars costalis and central tendon from a normal, 7-year-old, 20-kg, female, mixed-breed dog (A) and the affected Weimaraner (B) of Figure 2. Both specimens contain comparable areas of the pars costalis and central tendon. The diaphragmatic specimen of the affected Weimaraner is short, thick, and pale primarily from fibrosis (arrow) (marker=1 cm).


<bold>
  <italic toggle="yes">Figure 4</italic>
</bold>
—
Figure 4

This photomicrograph of the diaphragm of the affected Weimaraner with muscular dystrophy demonstrates areas of endomysial fibrosis (blue, A) that separate and surround hypertrophic (B), atrophic (C), and necrotic, fragmented (D) muscle fibers (Masson’s trichrome, bar=85 μm).


<bold>
  <italic toggle="yes">Figure 5</italic>
</bold>
—
Figure 5

This photomicrograph of the myocardium of the affected Weimaraner demonstrates marked myocardial fibrosis (A), which separates and surrounds atrophic cardiac myocytes (B), and areas of mineralization (C) (Hematoxylin and eosin stain, bar=25 μm).


  • Download PDF